Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription

Articles published in Hum Pathol

Retrieve available abstracts of 23 articles:
HTML format

Single Articles

    October 2020
  1. WU S, Xie L, Lin SX, Wirth GJ, et al
    Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence.
    Hum Pathol. 2020;104:96-104.
    PubMed     Abstract available

    August 2020
  2. SALLES DC, Mata DA, Epstein JI
    Significance of Paneth cell-like differentiation in prostatic adenocarcinoma: a retrospective cohort study of 80 cases.
    Hum Pathol. 2020;102:7-12.
    PubMed     Abstract available

    May 2020
  3. HEAPHY CM, Haffner MC, Graham MK, Lim D, et al
    Telomere lengths differ significantly between small cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.
    Hum Pathol. 2020 May 7. pii: S0046-8177(20)30086.
    PubMed     Abstract available

  4. ACOSTA AM, Taplin ME, Mata DA, D'Amico AV, et al
    Volume of Gleason pattern 4 stratifies risk of metastasis and death in patients with Gleason score 3+5=8/5+3=8 positive prostate core biopsies.
    Hum Pathol. 2020;99:62-74.
    PubMed     Abstract available

    April 2020
  5. HAFFNER MC, Salles DC, Gao G, Epstein JI, et al
    Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort.
    Hum Pathol. 2020;98:74-80.
    PubMed     Abstract available

    January 2020
  6. KRYVENKO ON, Williamson SR, Schwartz LE, Epstein JI, et al
    Gleason score 5+3=8 (grade group 4) prostate cancer - a rare occurrence with contemporary grading.
    Hum Pathol. 2020 Jan 7. pii: S0046-8177(19)30207.
    PubMed     Abstract available

    November 2019
  7. AL-HUSSAIN T, Haffner MC, Altaweel WM, Epstein JI, et al
    Plasmacytoid Acinar adenocarcinoma of the prostate: a newly described variant of prostate Cancer.
    Hum Pathol. 2019 Nov 4. pii: S0046-8177(19)30198.
    PubMed     Abstract available

    May 2019
  8. SEHGAL PD, Bauman TM, Nicholson TM, Vellky JE, et al
    Tissue-specific quantification and localization of androgen and estrogen receptors in prostate Cancer.
    Hum Pathol. 2019 May 2. pii: S0046-8177(19)30074.
    PubMed     Abstract available

    March 2019
  9. KAUR HB, Lu J, Guedes LB, Maldonado L, et al
    TP53 missense mutation is associated with increased tumor-infiltrating T-cells in primary prostate Cancer.
    Hum Pathol. 2019 Mar 6. pii: S0046-8177(19)30023.
    PubMed     Abstract available

  10. BELLUR S, Van der Kwast T, Mete O
    Evolving concepts in prostatic neuroendocrine manifestations: from focal divergent differentiation to amphicrine carcinoma.
    Hum Pathol. 2019;85:313-327.
    PubMed     Abstract available

    October 2018
  11. NAKAMURA Y, Ise K, McNamara KM, Azmahani A, et al
    The expression of sex steroid receptors and sex steroid-synthesizing/metabolizing enzymes in metastasized lymph nodes of prostate Cancer.
    Hum Pathol. 2018 Oct 2. pii: S0046-8177(18)30374.
    PubMed     Abstract available

    September 2018
  12. GORDETSKY JB, Ullman D, Schultz L, Porter KK, et al
    Histologic Findings Associated with False Positive Multiparametric Magnetic Resonance Imaging Performed for Prostate Cancer Detection.
    Hum Pathol. 2018 Sep 1. pii: S0046-8177(18)30337.
    PubMed     Abstract available

    May 2018
  13. MCCROSKEY Z, Koen TM, Lim DJ, Divatia MK, et al
    Prostatic adenocarcinoma in the setting of persistent mullerian duct syndrome: a case report.
    Hum Pathol. 2018;75:125-131.
    PubMed     Abstract available

    April 2018
  14. MERINO MJ, Peter A, Moreno V, Gil S, et al
    Morphological changes induced by Intraprostatic PSA-based vaccine in prostate Cancer biopsies (phase I clinical trial).
    Hum Pathol. 2018 Apr 27. pii: S0046-8177(18)30142.
    PubMed     Abstract available

    March 2018
  15. GORDETSKY JB, Schultz L, Porter KK, Nix JW, et al
    Defining the Optimal Method for Reporting Prostate Cancer Grade and Tumor Extent on MR/US Fusion Targeted Biopsies.
    Hum Pathol. 2018 Mar 15. pii: S0046-8177(18)30082.
    PubMed     Abstract available

    February 2018
  16. CHEN Z, Luo S, Chen Y, Xie X, et al
    High expression of NPRL2 is linked to poor prognosis in patients with prostate cancer.
    Hum Pathol. 2018 Feb 16. pii: S0046-8177(18)30052.
    PubMed     Abstract available

  17. ERICKSON A, Sandeman K, Lahdensuo K, Nordling S, et al
    New prostate cancer grade grouping system predicts survival after radical prostatectomy.
    Hum Pathol. 2018 Feb 12. pii: S0046-8177(18)30048.

    November 2017
  18. ACOSTA AM, Al Rasheed MRH, Rauscher GH, Vormittag E, et al
    Tumor Necrosis in Radical Prostatectomies with High-Grade Prostate Cancer is Associated with Multiple Poor Prognostic Features and a High Prevalence of Residual Disease.
    Hum Pathol. 2017 Nov 24. pii: S0046-8177(17)30434.
    PubMed     Abstract available

  19. SEIPEL AH, Whitington T, Delahunt B, Samaratunga H, et al
    Genetic profile of ductal adenocarcinoma of the prostate.
    Hum Pathol. 2017;69:1-7.
    PubMed     Abstract available

    July 2017
  20. TRUONG M, Rais-Bahrami S, Nix JW, Messing EM, et al
    Perineural Invasion by Prostate Cancer on MR/US Fusion Targeted Biopsy is Associated with Extraprostatic Extension and Early Biochemical Recurrence after Radical Prostatectomy.
    Hum Pathol. 2017 Jul 10. pii: S0046-8177(17)30239.
    PubMed     Abstract available

    June 2017
  21. GILANI S, Guo CC, Li-Ning EM, Pettaway C, et al
    Transformation of prostatic adenocarcinoma to well-differentiated neuroendocrine tumor after hormonal treatment.
    Hum Pathol. 2017;64:186-190.
    PubMed     Abstract available

    May 2017
  22. RONEN S, Abbott DW, Kravtsov O, Abdelkader A, et al
    PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform.
    Hum Pathol. 2017 May 10. pii: S0046-8177(17)30154.
    PubMed     Abstract available

  23. DE VIVAR AD, Sayeeduddin M, Rowley D, Cubilla A, et al
    Histologic features of stromogenic carcinoma of the prostate (carcinomas with reactive stroma grade 3).
    Hum Pathol. 2017;63:202-211.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.